Quarterly report · Q3
2931.TEDINET S100S8GB
Period2023-01-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥34.1bn | 2023-01-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥44.4bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥32.3bn | 2022-01-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | −¥959m | 2023-01-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | −¥2.3bn | 2022-01-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | −¥797m | 2023-01-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥2.5bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.1bn | 2022-01-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥780m | 2023-01-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥654m | 2022-01-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥1.3bn | 2023-01-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.7bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥873m | 2022-01-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥1.3bn | 2023-01-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | −¥876m | 2022-01-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥60.5bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥57.3bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥60.1bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥39.0bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥37.9bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥21.4bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥19.4bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥21.1bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥15.7bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.0bn | at 2022-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-10.86 | 2023-01-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.99 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-23.83 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.81 | 2022-01-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.61 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 35.5% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.0% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.4% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-09-30 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-09-30 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-09-30 | −¥1.3bn |
| jpcrp040300-q3r_E27054-000Biofuel Businessreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥1.8bn |
| jpcrp040300-q3r_E27054-000Biofuel Businessreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥1.8bn |
| jpcrp040300-q3r_E27054-000Biofuel Businessreportable segment | segment profit | 2023-01-01 → 2023-09-30 | −¥626m |
| jpcrp040300-q3r_E27054-000Health Care Businessreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥30.5bn |
| jpcrp040300-q3r_E27054-000Health Care Businessreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥30.5bn |
| jpcrp040300-q3r_E27054-000Health Care Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-09-30 | ¥0 |
| jpcrp040300-q3r_E27054-000Health Care Businessreportable segment | segment profit | 2023-01-01 → 2023-09-30 | ¥1.3bn |
| jpcrp040300-q3r_E27054-000Others Businessreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥1.8bn |
| jpcrp040300-q3r_E27054-000Others Businessreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥1.8bn |
| jpcrp040300-q3r_E27054-000Others Businessreportable segment | segment profit | 2023-01-01 → 2023-09-30 | −¥358m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-09-30 | ¥34.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-01-01 → 2023-09-30 | ¥34.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-01-01 → 2023-09-30 | ¥0 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-09-30 | ¥290m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-09-30 | −¥1.3bn |
| jpcrp040300-q3r_E27054-000Biofuel Businessreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥168m |
| jpcrp040300-q3r_E27054-000Biofuel Businessreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥168m |
| jpcrp040300-q3r_E27054-000Biofuel Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥555m |
| jpcrp040300-q3r_E27054-000Health Care Businessreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥30.3bn |
| jpcrp040300-q3r_E27054-000Health Care Businessreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥30.3bn |
| jpcrp040300-q3r_E27054-000Health Care Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥277m |
| jpcrp040300-q3r_E27054-000Others Businessreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q3r_E27054-000Others Businessreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥1.8bn |
| jpcrp040300-q3r_E27054-000Others Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥197m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-01-01 → 2022-09-30 | ¥32.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-01-01 → 2022-09-30 | ¥32.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-01-01 → 2022-09-30 | −¥1.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 462
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenue from contracts with customers | CurrentYTDDuration_jpcrp040300-q3r_E27054-000HealthCareBusinessReportableSegmentsMember | 30502000000 | JPY |
| Revenue from contracts with customers | CurrentYTDDuration_jpcrp040300-q3r_E27054-000BiofuelBusinessReportableSegmentsMember | 1770000000 | JPY |
| Revenue from contracts with customers | CurrentYTDDuration_jpcrp040300-q3r_E27054-000OthersBusinessReportableSegmentsMember | 1807000000 | JPY |
| Revenue from contracts with customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 34080000000 | JPY |
| Revenue from contracts with customers | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Revenue from contracts with customers | CurrentYTDDuration | 34080000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E27054-000HealthCareBusinessReportableSegmentsMember | 30502000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E27054-000BiofuelBusinessReportableSegmentsMember | 1770000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E27054-000OthersBusinessReportableSegmentsMember | 1807000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 34080000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | CurrentYTDDuration | 34080000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E27054-000HealthCareBusinessReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E27054-000BiofuelBusinessReportableSegmentsMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E27054-000OthersBusinessReportableSegmentsMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 0 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -0 | JPY |
| Transactions with other segments | CurrentYTDDuration | - | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E27054-000HealthCareBusinessReportableSegmentsMember | 30502000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E27054-000BiofuelBusinessReportableSegmentsMember | 1770000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E27054-000OthersBusinessReportableSegmentsMember | 1807000000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 34080000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -0 | JPY |
| Net sales | CurrentYTDDuration | 34080000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E27054-000HealthCareBusinessReportableSegmentsMember | 1275000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E27054-000BiofuelBusinessReportableSegmentsMember | -626000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E27054-000OthersBusinessReportableSegmentsMember | -358000000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 290000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -1250000000 | JPY |
| Operating income | CurrentYTDDuration | -959000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の4の7第1項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-11-13 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第19期第3四半期(自 2023年7月1日 至 2023年9月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社ユーグレナ | |
| Company name in english cover page | FilingDateInstant | Euglena Co.,Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 出雲 充 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都港区芝五丁目29番11号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 03-3453-4907 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)執行役員CFiO 若原 智広 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都港区芝五丁目29番11号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 03-3453-4907 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)執行役員CFiO 若原 智広 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E27054 | |
| Fund code | FilingDateInstant | - | |
| Security code | FilingDateInstant | 29310 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社ユーグレナ | |
| Filer name in english | FilingDateInstant | Euglena Co.,Ltd. |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |